EUVIMEDEUVIMED entdecken
Crossref

[ 68 Ga]Ga-NODAGA-SNA006 PET/CT Reveals CD8 + T-Cell Dynamics in Lung Cancer Progression and Anti–PD-1 Response

Jinxin Zhou, Yang Liu, Min Zhou, Wangxi Hai, Qidi Hu, Yifan Zhang, Qiurui Zhang

Journal of Nuclear Medicine · 2026-11 · 67 (11) · 1734-1740

DOI: 10.2967/jnumed.125.271377 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 27.08.2026. Verfasst von Jinxin Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Lung Neoplasms, CD8-Positive T-Lymphocytes, Gallium Radioisotopes. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heterogeneous response to anti-programmed cell death protein 1 (PD-1) immunotherapy in lung cancer necessitates reliable biomarkers for monitoring systemic CD8+ T-cell dynamics. This study used [68Ga]Ga-NODAGA-SNA006, a CD8-targeted PET tracer, to evaluate CD8+ T-cell distribution in relation to disease progression and treatment response.

Methods

Fourteen patients with stage II-IV lung cancer underwent baseline [68Ga]Ga-NODAGA-SNA006 PET/CT and blood CD8+ T-cell quantification. Eight patients receiving anti-PD-1-based chemoimmunotherapy underwent PET/CT and blood analyses before treatment and after 2 treatment cycles. SUVmax was measured in tumors (along with the tumor-to-background ratio), the spleen, the liver, and axial (sternum, T12, pelvis) and appendicular (femur) bone marrow. Correlations with disease stage, peripheral blood CD8+ T-cell quantification, programmed death ligand 1 (PD-L1) expression, and tumor reduction were assessed.

Results

Patients with stage IV disease patients exhibited a lower peripheral blood CD8+ T-cell count and percentage (P < 0.05), whereas the SUVmax in the spleen (P < 0.05) and axial bone marrow (sternum, T12, pelvis; P < 0.01) was higher than that in patients with earlier-stage disease. Peripheral blood CD8+ T-cell percentage was correlated with SUVmax in the spleen (r 2 = 0.38, P < 0.05) and axial bone marrow sites (most significant in sternum: r 2 = 0.68, P < 0.001). After anti-PD-1 therapy, analysis of combined "axial skeleton SUV" (sternum, T12, pelvis) revealed a significant interaction between time and PD-L1 group (P < 0.001): SUV increased in the low PD-L1 (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyLung NeoplasmsCD8-Positive T-LymphocytesGallium RadioisotopesProgrammed Cell Death 1 ReceptorDisease ProgressionAcetatesHumansFemaleMaleMiddle AgedAgedTreatment Outcome

Stichwörter der Autor:innen

CD8PET/CTimmunotherapylung cancerprognosis

Substanzen

Gallium RadioisotopesProgrammed Cell Death 1 ReceptorAcetatesGallium-68PDCD1 protein, human

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shanghai Key Laboratory of Emergency Prevention, Diagnosis and Treatment of Respiratory Infectious Diseases, Shanghai, China; and.
  • Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; shsmurui870822@163.com zyf11300@rjh.com.cn.
  • Department of Nuclear Medicine, Shanghai Clinical Research and Trial Center, Shanghai, China.

Zitieren

APA

Zhou, J., Liu, Y., Zhou, M., Hai, W., Hu, Q., Zhang, Y., & Zhang, Q. (2026). [ 68 Ga]Ga-NODAGA-SNA006 PET/CT Reveals CD8 + T-Cell Dynamics in Lung Cancer Progression and Anti–PD-1 Response. Journal of Nuclear Medicine, 67(11), 1734-1740. https://doi.org/10.2967/jnumed.125.271377

Vancouver

Zhou J, Liu Y, Zhou M, Hai W, Hu Q, Zhang Y, et al. [ 68 Ga]Ga-NODAGA-SNA006 PET/CT Reveals CD8 + T-Cell Dynamics in Lung Cancer Progression and Anti–PD-1 Response. Journal of Nuclear Medicine. 2026;67(11):1734-1740. doi:10.2967/jnumed.125.271377

BibTeX
@article{Zhou2026,
  author = {Zhou, Jinxin and Liu, Yang and Zhou, Min and Hai, Wangxi and Hu, Qidi and Zhang, Yifan and Zhang, Qiurui},
  title = {[ 68 Ga]Ga-NODAGA-SNA006 PET/CT Reveals CD8 + T-Cell Dynamics in Lung Cancer Progression and Anti–PD-1 Response},
  journal = {Journal of Nuclear Medicine},
  year = {2026},
  volume = {67},
  number = {11},
  pages = {1734--1740},
  doi = {10.2967/jnumed.125.271377}
}
Kostenlos starten →